PentaBind Company
PentaBind, shortlisted by Cancer Research UK as New Startup of the Year, is a cutting edge AI aptamer drug discovery firm that recently saved 38 years of manual drug design time, now awaiting imminent results on the next generation of aptamer drugs that have huge applications in cancer and other diseases.
Founded Date:
2021-01-01
Last Funding Date:
2024-01-11
Headquarters:
London,England,United Kingdom,Europe
Total Funding:
959000
Funding Status:
private
Industry:
Quantum Biology
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
959000
Last Funding Total Usd:
845000
Last Funding Total Currency:
USD
Last Funding Total Value:
845000
Founders:
Miguel Gonzalez Canudas,Phil Haynes,Rory Ryan